Table S2. HR+ and HER2- advanced breast cancer physical function impact concept frequencies and descriptions. (DOCX 17 kb
Association of background parenchymal uptake (BPU) with breast cancer for ipsilateral vs. contralate...
Kaplan-Meier analysis of clinico-pathological parameters in older patients. (DOCX 17Â kb
All data analysed during this study are included in this published article and its supplementary inf...
Table S3. HR+ and HER2- advanced breast cancer health and well-being impact concept descriptions. (D...
Table S1. HR+ and HER2- advanced breast cancer disease-related and treatment-related concept frequen...
Figure S2. Age-adjusted breast cancer-free interval by breast cancer molecular subtypesa. a Luminal ...
Figure S1. Age-adjusted overall survival by breast cancer molecular subtypesa. a Luminal A - ER posi...
Table S2. Multivariable adjusted Cox proportional hazard ratios (HRs) for overall mortality and brea...
Table S1. Multivariate-adjusteda hazard ratios (HRs) and 95% confidence intervals for breast cancer ...
Genes and probe sets used to characterize subgroups within ERâ/PgR+/HER2â phenotype. (DOC 40 kb
Gene expression by participant and clinical characteristics from CBCS Phase 3, 2008–2013. Table S2. ...
Forest plots with treatment effect ratios (TERs). The forest plots with the associated treatment eff...
Figure S2. Effect of trastuzumab on HER2 and HER3 levels. FACS analysis of HER2 and HER3 levels in A...
Table S3. Multivariable adjusted Cox proportional hazard ratios (HRs) for overall mortality and brea...
Predictors of the Diagnostic Interval. Table with results of the Cox Regression analysis (DOCX 15Â k...
Association of background parenchymal uptake (BPU) with breast cancer for ipsilateral vs. contralate...
Kaplan-Meier analysis of clinico-pathological parameters in older patients. (DOCX 17Â kb
All data analysed during this study are included in this published article and its supplementary inf...
Table S3. HR+ and HER2- advanced breast cancer health and well-being impact concept descriptions. (D...
Table S1. HR+ and HER2- advanced breast cancer disease-related and treatment-related concept frequen...
Figure S2. Age-adjusted breast cancer-free interval by breast cancer molecular subtypesa. a Luminal ...
Figure S1. Age-adjusted overall survival by breast cancer molecular subtypesa. a Luminal A - ER posi...
Table S2. Multivariable adjusted Cox proportional hazard ratios (HRs) for overall mortality and brea...
Table S1. Multivariate-adjusteda hazard ratios (HRs) and 95% confidence intervals for breast cancer ...
Genes and probe sets used to characterize subgroups within ERâ/PgR+/HER2â phenotype. (DOC 40 kb
Gene expression by participant and clinical characteristics from CBCS Phase 3, 2008–2013. Table S2. ...
Forest plots with treatment effect ratios (TERs). The forest plots with the associated treatment eff...
Figure S2. Effect of trastuzumab on HER2 and HER3 levels. FACS analysis of HER2 and HER3 levels in A...
Table S3. Multivariable adjusted Cox proportional hazard ratios (HRs) for overall mortality and brea...
Predictors of the Diagnostic Interval. Table with results of the Cox Regression analysis (DOCX 15Â k...
Association of background parenchymal uptake (BPU) with breast cancer for ipsilateral vs. contralate...
Kaplan-Meier analysis of clinico-pathological parameters in older patients. (DOCX 17Â kb
All data analysed during this study are included in this published article and its supplementary inf...
DOI
Add to ORKG